Journal
TRENDS IN PLANT SCIENCE
Volume 27, Issue 7, Pages 655-673Publisher
CELL PRESS
DOI: 10.1016/j.tplants.2022.03.001
Keywords
-
Categories
Funding
- VILLUM Center for Plant Plasticity [LP180100269]
- European Research Council [VKR023054]
- Lundbeck Foundation [ERC-2012-ADG 20120314]
- Novo Nordisk Foundation [R223-2016-85, NNF 16OC0021616, NNF 0054563, NNF 20OC0061048]
- Australian Research Council
- AstraZeneca [0071074]
- University of Queensland
- FKG [LP170100717]
- Australian Research Council [LP180100269] Funding Source: Australian Research Council
Ask authors/readers for more resources
By utilizing synthetic biology, it is now possible to expand the biosynthetic repertoire of plants and microalgae by using the chloroplast to increase the production of desired compounds. Separate commercialization of high-value compounds and improved bulk products can increase the economic potential and accelerate commercialization of the production system.
Using synthetic biology, it is now time to expand the biosynthetic repertoire of plants and microalgae by utilizing the chloroplast to augment the production of desired high-value compounds and of oil-, carbohydrate-, or protein-enriched biomass based on direct harvesting of solar energy and the consumption of CO2. Multistream product lines based on separate commercialization of the isolated high-value compounds and of the improved bulk products increase the economic potential of the light-driven production system and accelerate commercial scale up. Here we outline the scientific basis for the establishment of such green circular biomanufacturing systems and highlight recent results that make this a realistic option based on cross-disciplinary basic and applied research to advance long-term solutions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available